Last update :
19/11/2024
Anticancer drug   Daunorubicin hydrochloride  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cerubidin Denmark, Great Britain, Ireland, Norway, Sweden
Cerubidine Belgium, Canada, Chile, France, Luxembourg, Morocco, Netherlands, Switzerland, Tunisia, Turkey, United States of America
D Blastin Morocco
Daunac Colombia
Daunobin India
Daunoblastin Austria, Germany
Daunoblastina Greece, Hungary, Iran, Italy, Saudi Arabia, Spain, Venezuela
Daunocin India, Malaysia, Peru
Daunogobbi Argentina
Daunomed India, Peru
Daunomycin India
Daunoplus India
Daunorubicin Australia, Canada, Great Britain, New Zealand, United States of America
Daunorubicina Chile, Colombia, Ecuador, Mexico, Peru
Daunorubitec India
Daunoside India
Daunotec India, Venezuela
Daurocina Chile
Epodoxo Peru
Maxidauno Argentina, Ecuador
Oncodaunotec Colombia
Rubilem Mexico
Runabicon Colombia, Mexico
Zuleb Mexico
Stability of mixtures   injection   Stability of mixtures : Daunorubicin hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,45% Glucose 5% 0,03 mg/ml
injection   Daunorubicin hydrochloride   
injection   Cytarabine 0,26 mg/ml
injection   Etoposide 0,4 mg/ml
20°C
72 Hour
Light 643
Level of evidence D
Polypropylene Glucose 5% 0,0157 mg/ml
injection   Daunorubicin hydrochloride   
injection   Etoposide 0,157 mg/ml
injection   Cytarabine 0,157 mg/ml
25°C
48 Hour
With or without light 152
Joker
Polypropylene Glucose 5% 0,0157 mg/ml
injection   Daunorubicin hydrochloride   
injection   Etoposide 0,157 mg/ml
injection   Cytarabine 0,157 mg/ml
4°C
48 Hour
Protect from light 152
Joker

  Mentions Légales